Actively Recruiting
Prevention of Acute Cholecystitis With ETGBD
Led by Seoul National University Hospital · Updated on 2025-02-20
35
Participants Needed
1
Research Sites
144 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The goal of this clinical trial is to learn about Efficacy of the ETGBD parallel insertion with fully covered self-expandable metal stent for preventing acute cholecystitis in patients with low cystic duct insertion. In this study, we hypothesized that endoscopic transpapillary gallbladder drainage (ETGBD) with parallel insertion of a fully covered self-expanding metal stent(FCSEMS) through an endoscopic biliary drainage tunnel is superior in preventing complications such as cholecystitis when the gallbladder ducts confluence within the distal third of the common bile duct. And we aimed to confirm its efficacy by comparing the frequency, severity, and rate of invasive additional procedures due to cholecystitis complications to provide evidence of clinical utility.
CONDITIONS
Official Title
Prevention of Acute Cholecystitis With ETGBD
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults 19 years of age or older
- Patients requiring endoscopic retrograde cholangiography and drainage for therapeutic purposes
- Patients with imaging (CT, Cholangiogram) confirmed confluence of the cystic duct with the distal third of the common bile duct
- Patients who have voluntary informed consent to participate in the study
You will not qualify if you...
- Patients who have undergone percutaneous or surgical bile duct or gallbladder drainage prior to study enrollment
- Patients with anatomic deformity of the upper gastrointestinal tract after gastric or hepatobiliary surgery
- Patients with concomitant gastric or duodenal obstruction
- Patients with confirmed or suspected cystic duct obstruction on imaging studies
- Patients with acute cholecystitis or acute pancreatitis
- Patients who underwent cholecystectomy
- Patients with a life expectancy of less than 3 months
- Patients who are otherwise unable to undergo endoscopic retrograde cholangiopancreatography
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Seoul National University Hospital
Seoul, South Korea, 03080
Actively Recruiting
Research Team
M
Myeong Hwan Lee, MD.
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
PREVENTION
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here